Venture Investing In Biotech Still Strong, Says E&Y Report
This article was originally published in The Pink Sheet Daily
Executive Summary
The 27th annual Beyond Borders report shows continued constraints to funding for biotechs, as they cut R&D and deal with a changing development landscape, but VC funding remains resilient.